Capital Asset Advisory Services’s Core Laboratories CLB Stock Holding History

Capital Asset Advisory Services’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,603	Closed	-$516K	–	613
2021 Q3	$516K	Buy	18,603 +2,321	+14%	+$70.7K	0.06%	249
2021 Q2	$634K	Buy	+16,282	New	+$584K	0.07%	205
2021 Q1	–	Sell	-110	Closed	-$3K	–	808
2020 Q4	$3K	Buy	+110	New	+$2.25K	﹤0.01%	1363

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Capital Asset Advisory Services's CLB Position: Q4 2021 in Review

Capital Asset Advisory Services sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 18,603 shares — an estimated $516K sold.

Capital Asset Advisory Services first reported a position in CLB in Q4 2020 and held it in 3 quarters. The position peaked at $634K in Q2 2021. 174 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

Capital Asset Advisory Services reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
Capital Asset Advisory Services sold 18,603 Core Laboratories shares in Q4 2021, an estimated $516K.
Capital Asset Advisory Services first reported a position in Core Laboratories in Q4 2020 and held it in 3 quarters.
Capital Asset Advisory Services's Core Laboratories position peaked at $634K in Q2 2021.
174 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Capital Asset Advisory Services's 13F filing for Q4 2021, filed 4 Feb 2022.